Attached files
| file | filename |
|---|---|
| EX-10.2 - EXHIBIT 10.02 - VERDE BIO HOLDINGS, INC. | aphd_ex10z2.htm |
| EX-10.1 - EXHIBIT 10.01 - VERDE BIO HOLDINGS, INC. | aphd_ex10z1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported): January 15, 2020
APPIPHANY TECHNOLOGIES HOLDINGS CORP.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Nevada |
| 000-54524 |
| 30-0678378 |
(State or Other Jurisdiction |
| (Commission |
| (IRS Employer |
Salt Lake City UT 84111
(Address of Principal Executive Offices)
(972) 217-4080
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o |
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
o |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
o |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
o |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement.
Debt Financing
Effective January 15, 2020, Appiphany Technologies Holdings Corp. (the “Company”) entered into a Securities Purchase Agreement dated January 14, 2020 (“Purchase Agreement”) with GHS Investments, LLC (“GHS”). In conjunction with the Purchase Agreement, the Company has signed a Convertible Promissory Note for $35,000 (the “Note”). The Note contains an interest rate of ten percent (10%) per annum and has a maturity date of nine months following the date the funds are received. The amounts due under the Note are convertible at any time prior to the Maturity Date at a rate of 60% of the market price on the date prior to the execution of the Note.
A form of the Purchase Agreement and Note are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K.
Item 3.02 |
|
Unregistered Sales of Equity Securities. |
The information regarding the Subscription Agreement and the purchase of the Shares set forth in Item 1.01 is incorporated by reference into this Item 3.02.
Item 9.01 |
| Financial Statements and Exhibits. |
Exhibits. The following exhibits are being filed herewith:
Exhibit Number
10.1
10.2
|
|
|
Description of Exhibits
Securities Purchase Agreement.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 17h day of January, 2020.
|
|
|
|
|
| VERDE BIO HOLDINGS, INC.
|
| ||
| By: | /s/ Scott Cox |
| |
|
| Name: | Scott Cox |
|
|
| Title: | Chief Executive Officer |
|
| ||||
Exhibit Index to Current Report on Form 8-K
Exhibit Number
10.1 10.2
|
|
|
Description of Exhibits
|
|
|
|
|
|
|